FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone
01-05-2015
-31-10-2021
Show more information
Organisation
CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL